Clinical trials
Uterine Cervical Neoplasms trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 6 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Suspended | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical University of Vienna | 4 |
| Merck Sharp & Dohme LLC | 4 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Medical University Innsbruck | 2 |
| Amgen | 1 |
| Arbeitsgemeinschaft medikamentoese Tumortherapie | 1 |
| AstraZeneca | 1 |
| Canadian Cancer Trials Group | 1 |
| Clovis Oncology, Inc. | 1 |
| International Atomic Energy Agency | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 22 |
| Endometrial Neoplasms | 5 |
| Breast Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
| Vaginal Neoplasms | 2 |
| Adenocarcinoma of Lung | 1 |
| Biliary Tract Neoplasms | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.